Foundation For Innovative New Diagnostics, Switzerland
Clinical trials sponsored by Foundation For Innovative New Diagnostics, Switzerland, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Could a simple breath test replace needles for malaria diagnosis? Results expected Nov 2026 (estimated)
- New TB test could speed up detection of Drug-Resistant strains Results expected Jun 2027 (estimated)
-
New malaria test aims to catch hidden infections in pregnant women
Diagnosis CompletedMalaria in pregnancy often causes no symptoms, yet it can lead to anaemia, premature birth, and low birth weight. Standard rapid tests miss many of these quiet infections. Researchers are comparing a new high-sensitivity rapid diagnostic test with conventional tests in 930 pregna…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Diabetes devices put to the test: can home monitors match lab accuracy?
Diagnosis CompletedResearchers are evaluating four blood glucose meters and four HbA1c point-of-care devices to see how accurately they measure blood sugar and long-term glucose control compared with standard lab methods. The study includes people with diabetes, both adults and teenagers, some of w…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can a Finger-Prick blood test reveal hidden malaria in the placenta?
Diagnosis CompletedMalaria in pregnancy can hide in the placenta and harm both mother and baby, yet it often goes undetected. This study enrolls about 1,200 pregnant women in Africa to see whether malaria rapid diagnostic tests, blood smears, and PCR on maternal blood can accurately detect or predi…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Blood tests could replace painful spleen sampling for deadly parasite
Diagnosis CompletedVisceral leishmaniasis is a fatal parasitic disease if left untreated, and current methods to check whether treatment worked require invasive sampling of the spleen or bone marrow. Researchers at Gondar University Hospital in Ethiopia are evaluating blood-based immune and molecul…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 19, 2026 00:00 UTC
-
Can a digital assistant and quick tests stop unnecessary antibiotics for kids?
Diagnosis CompletedResearchers in Senegal are testing a new way to care for children under 15 who come to primary health clinics with fever or diarrhea. The strategy combines rapid tests for malaria, dengue, and strep A with a digital tool that suggests treatment based on symptoms and test results.…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can a digital assistant help clinics catch dengue fever faster?
Diagnosis CompletedDengue fever is common in Burkina Faso, but primary health clinics often rely only on malaria rapid tests when a child arrives with fever. Researchers are testing a digital module that walks health workers through the country's dengue management guideline and pairs it with dengue…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Mailing hepatitis c tests home could reach people who avoid clinics
Diagnosis CompletedResearchers in Georgia are testing whether mailing hepatitis C self-tests to people who inject drugs and men who have sex with men increases how many get tested. The trial enrolls 1,250 adults in Tbilisi and Batumi who do not know their hepatitis C status. Half receive a self-tes…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Home hepatitis c tests could reach thousands in pakistan
Diagnosis CompletedResearchers in Karachi, Pakistan, are studying whether delivering hepatitis C self-tests to people's homes increases how many get tested. The trial enrolls about 2,000 adults who live in two areas of the Malir district and have not recently been tested. Half receive a self-test k…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
Can At-Home hepatitis c tests reach people clinics miss?
Diagnosis CompletedResearchers are testing whether giving people in Malaysia a rapid hepatitis C self-test kit to use at home increases how many get tested, compared with standard clinic-based testing. The trial enrolls 750 adults who are not known to have hepatitis C and have not been tested in th…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 18, 2026 00:00 UTC
-
A single swab, two diseases: rapid test takes on TB and COVID-19
Diagnosis CompletedResearchers are testing a portable device called Truenat MTB Plus/COVID-19 to see if it can accurately detect both tuberculosis and COVID-19 from the same sample. The study will enroll about 2,000 adults who have symptoms like a long-lasting cough, fever, or weight loss, which co…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
New rapid mpox tests could speed up diagnosis in remote areas
Diagnosis CompletedThis study will check how well three new rapid tests detect mpox virus compared to a standard lab test. Researchers will use about 80 stored skin swab samples from Uganda. The goal is to see if these quick, portable tests are accurate enough for use in places without full labs.
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 06, 2026 00:00 UTC
-
Can newer tests match the gold standard for detecting Drug-Resistant TB?
Diagnosis CompletedThis study evaluates whether two newer line probe assays, the YD REBA MTB-MDR and Hain Genotype MTBDRplus V2, perform as well as the older Hain Genotype MTBDRplus V1 in detecting drug-resistant tuberculosis. Researchers will test stored, de-identified samples from adults with sym…
Sponsor: Foundation for Innovative New Diagnostics, Switzerland • Aim: Diagnosis
Last updated Sep 05, 2026 00:00 UTC